Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	422.38	457.46	445.94	442.31	419.67	365.95
Other Revenue	6.26	6.26	1.64	0.55	1.22	1.11
Revenue	428.64	463.72	447.58	442.87	420.89	367.06
Revenue Growth (YoY)	-8.73%	3.60%	1.06%	5.22%	14.67%	18.02%
Cost of Revenue	235.31	266.76	240.86	264.82	246.14	187.25
Gross Profit	193.34	196.96	206.73	178.04	174.75	179.81
Selling, General & Admin	115.13	116.12	99.72	56.03	63.1	71.71
Research & Development	36.93	35.82	43.86	26.97	24.43	27.84
Other Operating Expenses	6.27	4.19	4.36	5.3	4.47	5.33
Operating Expenses	156.71	156.42	148.25	89.14	92.11	103.96
Operating Income	36.63	40.54	58.48	88.91	82.64	75.85
Interest Expense	-0.04	-0.04	-	-	-	-1.83
Interest & Investment Income	14.83	15.4	15.97	1.33	0.96	0.11
Currency Exchange Gain (Loss)	-0.59	-0.59	1.15	1.55	-1.11	-0.55
Other Non Operating Income (Expenses)	-0.44	-2.03	0.09	-0.32	0.05	-0.38
EBT Excluding Unusual Items	50.39	53.29	75.7	91.47	82.55	73.2
Gain (Loss) on Sale of Investments	-0.13	0.8	0.54	-	-	-
Gain (Loss) on Sale of Assets	-0.84	-0.84	0.04	0.37	-0.04	-0.09
Asset Writedown	-0.31	-	-	-	-	-
Legal Settlements	-0.14	-0.14	-	-	-	-
Other Unusual Items	17.16	12.61	3.45	6.47	7.41	7.97
Pretax Income	66.13	65.71	79.74	98.3	89.92	81.08
Income Tax Expense	4.31	5.44	2.7	7.02	11.75	12.43
Net Income	61.83	60.27	77.04	91.28	78.17	68.65
Net Income to Common	61.83	60.27	77.04	91.28	78.17	68.65
Net Income Growth	-6.98%	-21.77%	-15.60%	16.77%	13.87%	127.73%
Shares Outstanding (Basic)	108	108	101	81	81	81
Shares Outstanding (Diluted)	108	108	101	81	81	81
Shares Change (YoY)	-0.47%	6.18%	24.38%	0.53%	-0.47%	0.34%
EPS (Basic)	0.57	0.56	0.76	1.12	0.96	0.84
EPS (Diluted)	0.57	0.56	0.76	1.12	0.96	0.84
EPS Growth	-6.55%	-26.32%	-32.14%	16.15%	14.40%	126.95%
Free Cash Flow	-305.55	-356.9	-33.12	84.75	31.83	98.04
Free Cash Flow Per Share	-2.84	-3.32	-0.33	1.04	0.39	1.20
Dividend Per Share	0.200	0.200	0.300	0.286	-	-
Dividend Growth	-33.33%	-33.33%	5.00%	-	-	-
Gross Margin	45.11%	42.47%	46.19%	40.20%	41.52%	48.99%
Operating Margin	8.55%	8.74%	13.06%	20.08%	19.63%	20.66%
Profit Margin	14.42%	13.00%	17.21%	20.61%	18.57%	18.70%
Free Cash Flow Margin	-71.28%	-76.96%	-7.40%	19.14%	7.56%	26.71%
EBITDA	78.52	83.84	107.43	122.54	109.5	101.2
EBITDA Margin	18.32%	18.08%	24.00%	27.67%	26.02%	27.57%
D&A For EBITDA	41.89	43.3	48.95	33.63	26.86	25.35
EBIT	36.63	40.54	58.48	88.91	82.64	75.85
EBIT Margin	8.55%	8.74%	13.06%	20.08%	19.63%	20.66%
Effective Tax Rate	6.52%	8.27%	3.38%	7.14%	13.06%	15.33%
Revenue as Reported	428.64	463.72	447.58	442.87	420.89	367.06
Advertising Expenses	-	4.03	1.89	-	-	-

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.